Redmile Group, LLC
Q1 2014 13F-HR Holdings
Net value change ($000)
+31,529
(3.9%)
New positions
19
Sold out positions
19
Turnover %
60.7%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q4 2013
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| A | 43,226 | NEW |
| Bausch Health | 39,171 | NEW |
| HCA | 25,816 | 129.1% |
| CASTLIGHT HEALTH, INC. | 25,132 | NEW |
| NEW RITE AID, LLC | 23,837 | NEW |
| ACTAVIS INC | 21,785 | 75.3% |
| PRTA | 21,198 | 8795.9% |
| Intra-Cellular Therapies, Inc. | 18,199 | NEW |
| ALGN | 15,258 | NEW |
| THC | 14,367 | 73.9% |
Top Reduces (Value $000, Stocks/ETFs)
| GILD | -48,644 | -100.0% |
| ZBH | -34,260 | -100.0% |
| CELG | -30,923 | -100.0% |
| AZN | -30,345 | -100.0% |
| INCY | -22,733 | -100.0% |
| OVERSEAS SHIPHOLDING GROUP INC | -21,964 | -99.0% |
| UHS | -16,683 | -100.0% |
| PFE | -16,418 | -100.0% |
| FOREST LAB | -13,693 | -100.0% |
| ST JUDE | -13,206 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|